Wesam Medical Holding, a Saudi healthcare investment company, has announced the signing of a strategic Memorandum of Understanding (MOU) with McLaren Health Care, one of the largest healthcare systems in the state of Michigan, United States, and operator of the Karmanos Cancer Institute, to establish a specialized hematology and oncology hospital in Riyadh.
Under the terms of the MOU, Wesam Medical Holding will oversee all legal, regulatory, and local market operations, while McLaren Health Care will be responsible for clinical, operational, and technical components, including hospital design and construction.
This partnership marks a significant milestone in Saudi Arabia’s healthcare sector, representing McLaren’s entry into the Kingdom to provide comprehensive, integrated services for hematology and oncology patients. The collaboration will extend the reach of the system’s renowned Karmanos Cancer Institute, designated by the U.S. National Cancer Institute as a Comprehensive Cancer Center.
The MOU was signed by Mr. Fahad Ibrahim Al-Khalaf, Chairman of Wesam Medical Holding Company, and Dr. Barton Buxton, President and Chief Executive Officer of McLaren Health Management Group, a subsidiary of McLaren Health Care. The partnership aims to transform oncology services in the Kingdom, aligning with the objectives of the Health Sector.
